{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:23:58Z","timestamp":1788794638777,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"am","delay-in-days":345,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ajem.2024.11.017","type":"journal-article","created":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T01:54:01Z","timestamp":1731203641000},"page":"216.e5-216.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Successful recovery of vision following intravenous thrombolysis using low-dose alteplase in central retinal artery occlusion"],"prefix":"10.1016","volume":"87","author":[{"given":"Shun","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikito","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniharu","family":"Tasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohei","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisayuki","family":"Hosoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiki","family":"Marushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yamagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Oshika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Matsumaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2024.11.017_bb0005","first-page":"4","article-title":"Central retinal artery occlusion: a review of pathophysiological features and management","author":"Dagra","year":"2024","journal-title":"Stroke Vascul Intervent Neurol"},{"key":"10.1016\/j.ajem.2024.11.017_bb0010","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1161\/STR.0000000000000366","article-title":"Management of Central Retinal Artery Occlusion: a scientific statement from the American Heart Association","volume":"52","author":"Mac Grory","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.ajem.2024.11.017_bb0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-041104","article-title":"Nationwide incidence of central retinal artery occlusion in Japan: an exploratory descriptive study using the National Database of health insurance claims (2011-2015)","volume":"10","author":"Kido","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajem.2024.11.017_bb0020","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jamaneurol.2015.1578","article-title":"Intravenous fibrinolytic therapy in central retinal artery occlusion: a patient-level meta-analysis","volume":"72","author":"Schrag","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ajem.2024.11.017_bb0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11940-012-0202-9","article-title":"Treatment options for central retinal artery occlusion","volume":"15","author":"Cugati","year":"2013","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.ajem.2024.11.017_bb0030","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/ICU.0b013e328329b5d5","article-title":"Thrombolytic therapy in central retinal artery occlusion: cutting edge therapy, standard of care therapy, or impractical therapy?","volume":"20","author":"Hazin","year":"2009","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ajem.2024.11.017_bb0035","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2147\/OPTH.S121307","article-title":"Reversibility of retinal ischemia due to central retinal artery occlusion by hyperbaric oxygen","volume":"11","author":"Hadanny","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajem.2024.11.017_bb0040","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1161\/STROKEAHA.119.028743","article-title":"Intravenous fibrinolysis for central retinal artery occlusion: a cohort study and updated patient-level meta-analysis","volume":"51","author":"Mac Grory","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.ajem.2024.11.017_bb0045","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/STROKEAHA.120.032453","article-title":"Embolic stroke of undetermined source and patent foramen Ovale: risk of paradoxical embolism score validation and atrial fibrillation prediction","volume":"52","author":"Strambo","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.ajem.2024.11.017_bb0050","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/jamaneurol.2020.0458","article-title":"Proposal for updated nomenclature and classification of potential causative mechanism in patent foramen ovale-associated stroke","volume":"77","author":"Elgendy","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ajem.2024.11.017_bb0055","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/eye.2009.142","article-title":"Vascular risk factors for central retinal artery occlusion","volume":"24","author":"Rudkin","year":"2010","journal-title":"Eye (Lond)"},{"issue":"1367\u201375","key":"10.1016\/j.ajem.2024.11.017_bb0060","article-title":"Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial","volume":"117","author":"Schumacher","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajem.2024.11.017_bb0065","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ajo.2023.09.003","article-title":"Yield of investigations in young patients presenting with transient monocular vision loss: a prospective study","volume":"257","author":"Sverdlichenko","year":"2024","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajem.2024.11.017_bb0070","first-page":"14","article-title":"Ocular manifestations and complications of patent foramen ovale: a narrative review","author":"Lixi","year":"2024","journal-title":"J Pers Med"},{"key":"10.1016\/j.ajem.2024.11.017_bb0075","first-page":"38","article-title":"Transthoracic echocardiography in young patients with acute retinal arterial obstruction. RECO study group. Retinal emboli of cardiac origin group","volume":"32","author":"Sharma","year":"1997","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.ajem.2024.11.017_bb0080","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3389\/fneur.2020.00567","article-title":"Patent foramen Ovale in cryptogenic ischemic stroke: direct cause, risk factor, or incidental finding?","volume":"11","author":"Ioannidis","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.ajem.2024.11.017_bb0085","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/STROKEAHA.123.040546","article-title":"Patent foramen ovale management for secondary stroke prevention: state-of-the-art appraisal of current evidence","volume":"55","author":"Sposato","year":"2024","journal-title":"Stroke"},{"key":"10.1016\/j.ajem.2024.11.017_bb0090","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/01.STR.0000227191.01792.e3","article-title":"Alteplase at 0.6 mg\/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase clinical trial (J-ACT)","volume":"37","author":"Yamaguchi","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.ajem.2024.11.017_bb0095","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1161\/STROKEAHA.110.589606","article-title":"Thrombolysis with 0.6 mg\/kg intravenous alteplase for acute ischemic stroke in routine clinical practice: the Japan post-marketing Alteplase registration study (J-MARS)","volume":"41","author":"Nakagawara","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.ajem.2024.11.017_bb0100","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa1515510","article-title":"Low-dose versus standard-dose intravenous Alteplase in acute ischemic stroke","volume":"374","author":"Anderson","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2024.11.017_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105988","article-title":"Acute central retinal artery occlusion seen within 24 hours at a tertiary institution","volume":"30","author":"Chan","year":"2021","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.ajem.2024.11.017_bb0110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.10.11.2","article-title":"Risk of stroke, myocardial infarction, and death among patients with retinal artery occlusion and the effect of antithrombotic treatment","volume":"10","author":"Vestergaard","year":"2021","journal-title":"Transl Vis Sci Technol"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675724005953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675724005953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T15:29:47Z","timestamp":1734017387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675724005953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":22,"alternative-id":["S0735675724005953"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2024.11.017","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful recovery of vision following intravenous thrombolysis using low-dose alteplase in central retinal artery occlusion","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2024.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}